OCTREOPHARM SCIENCES
OctreoPharm Sciences GmbH is a Berlin, Germany-based a biopharmaceutical company that focuses on the development of new radio pharmaceuticals for neuroendocrine tumours.
OCTREOPHARM SCIENCES
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.octreopharmsciences.com
Total Employee:
11+
Status:
Active
Total Funding:
5 M EUR
Similar Organizations
AlzeCure Pharma AB
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD.
Covalys Biosciences
Covalys Biosciences is engaged in the development and production of tools for protein research.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Founder
Investors List
IBB Ventures
IBB Ventures investment in Venture Round - OctreoPharm Sciences
KfW
KfW investment in Venture Round - OctreoPharm Sciences
Official Site Inspections
http://www.octreopharmsciences.com
- Host name: 104.21.54.235
- IP address: 104.21.54.235
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OctreoPharm Sciences"
company - OctreoPharm Sciences GmbH
About OctreoPharm Sciences GmbH OctreoPharm Sciences GmbH (OPS), located at the Biomedical Research Campus in Berlin-Buch (Germany), is a privately held clinical …See details»
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Theranostics: Accelerating the Promises. The creativity of oncologists, radiochemists and nuclear medicine physicians gave the impulses. We just make …See details»
OctreoPharm Sciences - Crunchbase Company Profile …
Organization. OctreoPharm Sciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
OctreoPharm Sciences Company Profile 2024: …
OctreoPharm Sciences General Information Description. Developer of radioactively labeled pharmaceuticals. The company is focused on the …See details»
OctreoPharm Sciences GmbH - Company Profile & Staff Directory
OctreoPharm Sciences GmbH is a privately held biopharmaceutical company focusing on the development of radiopharmaceuticals. The Berlin (Germany) based company is located on the …See details»
OctreoPharm Sciences GmbH - Company Profile and News
Company profile page for OctreoPharm Sciences GmbH including stock price, company news, executives, board members, and contact informationSee details»
OctreoPharm Sciences GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OctreoPharm Sciences GmbH of Berlin, Berlin. Get the latest business insights from Dun & Bradstreet.See details»
OctreoPharm Sciences - VentureRadar
OctreoPharm Sciences GmbH is a biopharmaceutical company focusing on radioactive labeled drugs. Particularly, the company develops novel radiopharmaceuticals in the field of …See details»
OctreoPharm Sciences - Funding, Financials, Valuation & Investors
OctreoPharm Sciences is focused on the development of new radio pharmaceuticals for neuroendocrine tumors. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
OctreoPharm Sciences - Tech Stack, Apps, Patents & Trademarks
OctreoPharm Sciences is focused on the development of new radio pharmaceuticals for neuroendocrine tumors.See details»
OctreoPharm Sciences GmbH: Pioneering Advances in …
Jun 27, 2024 OctreoPharm Sciences GmbH has emerged as a leading force in the realm of pharmaceutical research and development. Founded on a commitment to innovation and …See details»
Ipsen signs agreement to acquire Octreopharm Sciences
May 20, 2015 Ipsen has announced the signature of an agreement to acquire OctreoPharm Sciences, a private German life sciences company focusing on the development of innovative …See details»
Ipsen S.A. completed the acquisition of OctreoPharm Sciences …
Jun 29, 2015 Ipsen S.A. (ENXTPA:IPN) agreed to acquire OctreoPharm Sciences GmbH from Eckert & Ziegler Radiopharma Gmbh and others for €50 million on May 19, 2015. The …See details»
Ipsen acquires Octreopharm Sciences | Reuters
May 19, 2015 * Octreopharm's shareholders are eligible to receive up to a total of about 50 million euros ($56 million) for purchase of 100 percent of company's sharesSee details»
EMA grants orphan drug status to OctreoPharm's OPS202 for …
Jan 29, 2014 OctreoPharm Sciences founder and senior advisor Udo Blaseg said the orphan drug status entitles the company to ten year market exclusivity in Europe following marketing …See details»
news media - OctreoPharm Sciences GmbH
Www.octreopharmsciences.com. Previous news. Press Release of OctreoPharm Sciences GmbH, 16.10.2014. OctreoPharm Sciences Gets FDA Orphan Drug Designation for Management of …See details»
Ipsen acquires OctreoPharm to boost its oncology presence
May 21, 2015 Ipsen has acquired the private German life sciences company OctreoPharm Sciences for $50m. OctreoPharm focuses on the development of innovative radioactive …See details»
Ipsen acquires OctreoPharm Sciences for €50m - Manufacturing …
May 20, 2015 French biotechnology company Ipsen has signed an agreement to purchase OctreoPharm Sciences for €50m. OctreoPharm is a privately owned German life sciences …See details»
OctreoPharm Sciences GmbH Granted Global and Exclusive …
Oct 6, 2011 OctreoPharm Sciences GmbH Campus Berlin-Buch Robert-Rössle-Straße 10 13125 Berlin Phone: +49(0)30-9489-3360 eMail: [email protected] SOURCE OctreoPharm.See details»
OctreoPharm Sciences GmbH Granted Global and Exclusive …
BERLIN, October 6, 2011 /PRNewswire/ -- OctreoPharm Sciences GmbH, a Berlin-based specialist in nuclear medical pharmaceuticals (radiopharmaceuticals), announced today that it …See details»